Lenacapavir offering new hope for HIV prevention?

The United Nations has warned that nearly three million children could contract HIV by 2040, with more than half at risk of dying from AIDS-related illnesses if prevention and treatment efforts are not significantly expanded. The agency says the overwhelming majority of these infections are expected to occur in sub-Saharan Africa, where young people remain disproportionately affected by the epidemic. Amid these concerns, a major scientific breakthrough is offering new hope. Lenacapavir, a long-acting HIV prevention injection administered just twice a year, is being hailed as a potential game-changer, particularly for young people and others who struggle to adhere to daily prevention pills.

In United States, Minnesota , the fentanyl epidemic continues to devastate families and communities, with overdose deaths leaving a lasting toll.

Presenter: Nkechi Ogbonna Producers: Blessing Aderogba Technical Producer: Herbert Masua Senior Producer: Keikantse Shumba Editors: Charles Gitonga and Maryam Abdalla